Simvastatin reduces antiphospholipid antibodies formation in patients with systemic lupus erythematosus: a preliminary study

Abstract

Get full access to this article

View all access options for this article.

References

Watanabe

Oku

Amengual

et al.

Effects of statins on thrombosis development in patients with systemic lupus erythematosus and antiphospholipid antibodies. Lupus 2018; 27: 225−234.

Erkan

Willis

Murthy

et al.

A prospective open-label pilot study of fluvastatin on proinflammatory and prothrombotic biomarkers in antiphospholipid antibody positive patients. Ann Rheum Dis 2014; 73: 1176−1180.

Jajoria

Murthy

Papalardo

Romay-Penabad

Gleason

Pierangeli

. Statins for the treatment of antiphospholipid syndrome? Ann N Y Acad Sci 2009; 1173: 736−745.

Kotyla

. The role of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors (statins) in modern rheumatology. Ther Adv Musculoskelet Dis 2010; 2: 257−269.

Willis

Seif

McGwin

Jr. et al.

Effects of statins on proinflammatory/prothrombotic biomarkers and on disease activity scores in SLE patients: Data from LUMINA (LXXVI), a multi-ethnic US cohort. Clin Exp Rheumatol 2014; 32: 162−167.